In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
During the COVID-19 crisis, managed care professionals are facing unique challenges to deliver patient care. This resource center is designed to aggregate timely information for AMCP members and stakeholders.
The Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) was established to address anticipated needs for post-marketed evidence generation for novel biologics, their corresponding biosimilars and other related products.
Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.
Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent action on Capitol Hill surrounding pharmacy benefit manager reform.
May 2023 Legislative & Regulatory Briefing: AMCP’s Jennifer Mathieu Shares Tactics for Expanding Access to PDTs; ICYMI: Law CPE Sessions from AMCP 2023 Now Available on AMCP Learn; AMCP Submits Comments on Race and Ethnicity Statistical Standards; CMS Issues Final Medicare Part D DIR Reporting Guidance; Register Your Organization for the AMCP IRA Workshop Series.